Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons

Abstract Protein/protein interactions (PPI) play crucial roles in neuronal functions. Yet, their potential as drug targets for brain disorders remains underexplored. The fibroblast growth factor 14 (FGF14)/voltage-gated Na+ channel 1.6 (Nav1.6) complex regulates excitability of medium spiny neurons...

Full description

Saved in:
Bibliographic Details
Main Authors: Nolan M. Dvorak, Paul A. Wadsworth, Guillermo Aquino-Miranda, Pingyuan Wang, Douglas S. Engelke, Jingheng Zhou, Nghi Nguyen, Aditya K. Singh, Giuseppe Aceto, Zahra Haghighijoo, Isabella I. Smith, Nana Goode, Mingxiang Zhou, Yosef Avchalumov, Evan P. Troendle, Cynthia M. Tapia, Haiying Chen, Reid T. Powell, Timothy J. Baumgartner, Jully Singh, Leandra Koff, Jessica Di Re, Ann E. Wadsworth, Mate Marosi, Marc R. Azar, Kristina Elias, Paul Lehmann, Yorkiris M. Mármol Contreras, Poonam Shah, Hector Gutierrez, Thomas A. Green, Martin B. Ulmschneider, Marcello D’Ascenzo, Clifford Stephan, Guohong Cui, Fabricio H. Do Monte, Jia Zhou, Fernanda Laezza
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-55554-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850075751729070080
author Nolan M. Dvorak
Paul A. Wadsworth
Guillermo Aquino-Miranda
Pingyuan Wang
Douglas S. Engelke
Jingheng Zhou
Nghi Nguyen
Aditya K. Singh
Giuseppe Aceto
Zahra Haghighijoo
Isabella I. Smith
Nana Goode
Mingxiang Zhou
Yosef Avchalumov
Evan P. Troendle
Cynthia M. Tapia
Haiying Chen
Reid T. Powell
Timothy J. Baumgartner
Jully Singh
Leandra Koff
Jessica Di Re
Ann E. Wadsworth
Mate Marosi
Marc R. Azar
Kristina Elias
Paul Lehmann
Yorkiris M. Mármol Contreras
Poonam Shah
Hector Gutierrez
Thomas A. Green
Martin B. Ulmschneider
Marcello D’Ascenzo
Clifford Stephan
Guohong Cui
Fabricio H. Do Monte
Jia Zhou
Fernanda Laezza
author_facet Nolan M. Dvorak
Paul A. Wadsworth
Guillermo Aquino-Miranda
Pingyuan Wang
Douglas S. Engelke
Jingheng Zhou
Nghi Nguyen
Aditya K. Singh
Giuseppe Aceto
Zahra Haghighijoo
Isabella I. Smith
Nana Goode
Mingxiang Zhou
Yosef Avchalumov
Evan P. Troendle
Cynthia M. Tapia
Haiying Chen
Reid T. Powell
Timothy J. Baumgartner
Jully Singh
Leandra Koff
Jessica Di Re
Ann E. Wadsworth
Mate Marosi
Marc R. Azar
Kristina Elias
Paul Lehmann
Yorkiris M. Mármol Contreras
Poonam Shah
Hector Gutierrez
Thomas A. Green
Martin B. Ulmschneider
Marcello D’Ascenzo
Clifford Stephan
Guohong Cui
Fabricio H. Do Monte
Jia Zhou
Fernanda Laezza
author_sort Nolan M. Dvorak
collection DOAJ
description Abstract Protein/protein interactions (PPI) play crucial roles in neuronal functions. Yet, their potential as drug targets for brain disorders remains underexplored. The fibroblast growth factor 14 (FGF14)/voltage-gated Na+ channel 1.6 (Nav1.6) complex regulates excitability of medium spiny neurons (MSN) of the nucleus accumbens (NAc), a central hub of reward circuitry that controls motivated behaviors. Here, we identified compound 1028 (IUPAC: ethyl 3-(2-(3-(hydroxymethyl)-1H-indol-1-yl)acetamido)benzoate), a brain-permeable small molecule that targets FGF14R117, a critical residue located within a druggable pocket at the FGF14/Nav1.6 PPI interface. We found that 1028 modulates FGF14/Nav1.6 complex assembly and depolarizes the voltage-dependence of Nav1.6 channel inactivation with nanomolar potency by modulating the intramolecular interaction between the III-IV linker and C-terminal domain of the Nav1.6 channel. Consistent with the compound’s effects on Nav1.6 channel inactivation, 1028 enhances MSN excitability ex vivo and accumbal neuron firing rate in vivo in murine models. Systemic administration of 1028 maintains behavioral motivation preferentially during motivationally deficient conditions in murine models. These behavioral effects were abrogated by in vivo gene silencing of Fgf14 in the NAc and were accompanied by a selective reduction in accumbal dopamine levels during reward consumption in murine models. These findings underscore the potential to selectively regulate complex behaviors associated with neuropsychiatric disorders through targeting of PPIs in neurons.
format Article
id doaj-art-5bdbd67a4c3444fa90812b37bab635dc
institution DOAJ
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-5bdbd67a4c3444fa90812b37bab635dc2025-08-20T02:46:13ZengNature PortfolioNature Communications2041-17232025-01-0116112710.1038/s41467-024-55554-7Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neuronsNolan M. Dvorak0Paul A. Wadsworth1Guillermo Aquino-Miranda2Pingyuan Wang3Douglas S. Engelke4Jingheng Zhou5Nghi Nguyen6Aditya K. Singh7Giuseppe Aceto8Zahra Haghighijoo9Isabella I. Smith10Nana Goode11Mingxiang Zhou12Yosef Avchalumov13Evan P. Troendle14Cynthia M. Tapia15Haiying Chen16Reid T. Powell17Timothy J. Baumgartner18Jully Singh19Leandra Koff20Jessica Di Re21Ann E. Wadsworth22Mate Marosi23Marc R. Azar24Kristina Elias25Paul Lehmann26Yorkiris M. Mármol Contreras27Poonam Shah28Hector Gutierrez29Thomas A. Green30Martin B. Ulmschneider31Marcello D’Ascenzo32Clifford Stephan33Guohong Cui34Fabricio H. Do Monte35Jia Zhou36Fernanda Laezza37Department of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Neurobiology and Anatomy, University of Texas Health Science CenterDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Neurobiology and Anatomy, University of Texas Health Science CenterNeurobiology Laboratory, National Institute of Environmental Health Sciences, Research Triangle ParkHigh-Throughput Research and Screening Center, Texas A&M Health Science CenterDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Neuroscience, Università Cattolica del Sacro CuoreDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Neurobiology and Anatomy, University of Texas Health Science CenterDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Chemistry, King’s College London 7 Trinity StreetDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchHigh-Throughput Research and Screening Center, Texas A&M Health Science CenterDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchBehavioral Pharma Inc., 505 Coast Blvd. South, Suite 212Behavioral Pharma Inc., 505 Coast Blvd. South, Suite 212Department of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Chemistry, King’s College London 7 Trinity StreetDepartment of Neuroscience, Università Cattolica del Sacro CuoreHigh-Throughput Research and Screening Center, Texas A&M Health Science CenterNeurobiology Laboratory, National Institute of Environmental Health Sciences, Research Triangle ParkDepartment of Neurobiology and Anatomy, University of Texas Health Science CenterDepartment of Pharmacology and Toxicology, University of Texas Medical BranchDepartment of Pharmacology and Toxicology, University of Texas Medical BranchAbstract Protein/protein interactions (PPI) play crucial roles in neuronal functions. Yet, their potential as drug targets for brain disorders remains underexplored. The fibroblast growth factor 14 (FGF14)/voltage-gated Na+ channel 1.6 (Nav1.6) complex regulates excitability of medium spiny neurons (MSN) of the nucleus accumbens (NAc), a central hub of reward circuitry that controls motivated behaviors. Here, we identified compound 1028 (IUPAC: ethyl 3-(2-(3-(hydroxymethyl)-1H-indol-1-yl)acetamido)benzoate), a brain-permeable small molecule that targets FGF14R117, a critical residue located within a druggable pocket at the FGF14/Nav1.6 PPI interface. We found that 1028 modulates FGF14/Nav1.6 complex assembly and depolarizes the voltage-dependence of Nav1.6 channel inactivation with nanomolar potency by modulating the intramolecular interaction between the III-IV linker and C-terminal domain of the Nav1.6 channel. Consistent with the compound’s effects on Nav1.6 channel inactivation, 1028 enhances MSN excitability ex vivo and accumbal neuron firing rate in vivo in murine models. Systemic administration of 1028 maintains behavioral motivation preferentially during motivationally deficient conditions in murine models. These behavioral effects were abrogated by in vivo gene silencing of Fgf14 in the NAc and were accompanied by a selective reduction in accumbal dopamine levels during reward consumption in murine models. These findings underscore the potential to selectively regulate complex behaviors associated with neuropsychiatric disorders through targeting of PPIs in neurons.https://doi.org/10.1038/s41467-024-55554-7
spellingShingle Nolan M. Dvorak
Paul A. Wadsworth
Guillermo Aquino-Miranda
Pingyuan Wang
Douglas S. Engelke
Jingheng Zhou
Nghi Nguyen
Aditya K. Singh
Giuseppe Aceto
Zahra Haghighijoo
Isabella I. Smith
Nana Goode
Mingxiang Zhou
Yosef Avchalumov
Evan P. Troendle
Cynthia M. Tapia
Haiying Chen
Reid T. Powell
Timothy J. Baumgartner
Jully Singh
Leandra Koff
Jessica Di Re
Ann E. Wadsworth
Mate Marosi
Marc R. Azar
Kristina Elias
Paul Lehmann
Yorkiris M. Mármol Contreras
Poonam Shah
Hector Gutierrez
Thomas A. Green
Martin B. Ulmschneider
Marcello D’Ascenzo
Clifford Stephan
Guohong Cui
Fabricio H. Do Monte
Jia Zhou
Fernanda Laezza
Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
Nature Communications
title Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
title_full Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
title_fullStr Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
title_full_unstemmed Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
title_short Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6 complex in nucleus accumbens neurons
title_sort enhanced motivated behavior mediated by pharmacological targeting of the fgf14 nav1 6 complex in nucleus accumbens neurons
url https://doi.org/10.1038/s41467-024-55554-7
work_keys_str_mv AT nolanmdvorak enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT paulawadsworth enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT guillermoaquinomiranda enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT pingyuanwang enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT douglassengelke enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT jinghengzhou enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT nghinguyen enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT adityaksingh enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT giuseppeaceto enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT zahrahaghighijoo enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT isabellaismith enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT nanagoode enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT mingxiangzhou enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT yosefavchalumov enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT evanptroendle enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT cynthiamtapia enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT haiyingchen enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT reidtpowell enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT timothyjbaumgartner enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT jullysingh enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT leandrakoff enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT jessicadire enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT annewadsworth enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT matemarosi enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT marcrazar enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT kristinaelias enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT paullehmann enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT yorkirismmarmolcontreras enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT poonamshah enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT hectorgutierrez enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT thomasagreen enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT martinbulmschneider enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT marcellodascenzo enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT cliffordstephan enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT guohongcui enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT fabriciohdomonte enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT jiazhou enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons
AT fernandalaezza enhancedmotivatedbehaviormediatedbypharmacologicaltargetingofthefgf14nav16complexinnucleusaccumbensneurons